Non-Statin Cholesterol-Lowering Drug Linked to Lower Cancer Risk

Cholesterol absorption inhibitors, like statins, are associated with a reduced risk of developing liver cancer. Previous research has indicated that statins, cholesterol-lowering medications, may reduce the risk of developing liver cancer. In a new study published in CANCER, a peer-reviewed journal of the American Cancer Society, researchers investigated whether non-statin cholesterol-lowering drugs have similar effects. […] Read More